Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration
Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first
diagnosed at the time of stroke. Detecting asymptomatic AF would provide an opportunity to …
diagnosed at the time of stroke. Detecting asymptomatic AF would provide an opportunity to …
[HTML][HTML] Diabetes mellitus and heart failure
M Lehrke, N Marx - The American journal of cardiology, 2017 - Elsevier
Epidemiologic and clinical data from the last 2 decades have shown that the prevalence of
heart failure in diabetes is very high, and the prognosis for patients with heart failure is …
heart failure in diabetes is very high, and the prognosis for patients with heart failure is …
[PDF][PDF] 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …
[HTML][HTML] Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation
Background Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the
standard of care after percutaneous coronary intervention (PCI) for patients with atrial …
standard of care after percutaneous coronary intervention (PCI) for patients with atrial …
[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease
V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …
when exercising their clinical judgment, as well as in the determination and the …
Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study
JPJ Halcox, K Wareham, A Cardew, M Gilmore… - Circulation, 2017 - Am Heart Assoc
Background: Asymptomatic atrial fibrillation (AF) is increasingly common in the aging
population and implicated in many ischemic strokes. Earlier identification of AF with …
population and implicated in many ischemic strokes. Earlier identification of AF with …
Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study
S Prabhu, AJ Taylor, BT Costello, DM Kaye… - Journal of the American …, 2017 - jacc.org
Background: Atrial fibrillation (AF) and left ventricular systolic dysfunction (LVSD) frequently
co-exist despite adequate rate control. Existing randomized studies of AF and LVSD of …
co-exist despite adequate rate control. Existing randomized studies of AF and LVSD of …
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT
IC Van Gelder, JS Healey, HJGM Crijns… - European heart …, 2017 - academic.oup.com
Background ASSERT demonstrated that subclinical atrial fibrillation (SCAF) is common in
pacemaker patients without prior AF and is associated with increased risk of ischemic stroke …
pacemaker patients without prior AF and is associated with increased risk of ischemic stroke …
[HTML][HTML] Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation
H Calkins, S Willems, EP Gerstenfeld… - … England Journal of …, 2017 - Mass Medical Soc
Background Catheter ablation of atrial fibrillation is typically performed with uninterrupted
anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant …
anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant …
[HTML][HTML] Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up …
LV Boersma, H Ince, S Kische, E Pokushalov… - Heart rhythm, 2017 - Elsevier
Background Left atrial appendage (LAA) occlusion with WATCHMAN has emerged as viable
alternative to vitamin K antagonists in randomized controlled trials. Objective EWOLUTION …
alternative to vitamin K antagonists in randomized controlled trials. Objective EWOLUTION …